Skip to main content
Fig. 4 | International Journal of Retina and Vitreous

Fig. 4

From: Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits

Fig. 4

Histologic examination of the central retina for PRO-169 (a) vs ranibizumab (b) after the 1st Ivt injection (D32), for PRO-169 (c) vs ranibizumab (d) after the 2nd Ivt injection (D63), and for PRO-169 (e) vs ranibizumab (f) after the 3rd Ivt injection (D94). No retinal toxicity was found in any eyes (x40)

Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us